All updated as on -
From 2024–2031, the worldwide cyclodextrin market is projected to grow at a CAGR of 5.4%, reaching a value of USD 365.67 million in the end. Rising consumption of dietary supplements and the development of tablet medicines are driving factors in the anticipated expansion of the cyclodextrin market. The increasing demand for orally administered medications across the pharmaceutical sector is creating an advantageous environment for the Cyclodextrin market.
In cyclodextrins, a type of complex cyclic sugar, alpha-1,4 glycosidic bonds link glucose subunits into a macrocyclic ring. Creating cyclodextrin involves breaking down starch into simpler molecules using an enzyme. Cyclodextrin is finding increasing use as a solvent component in medication delivery across the chemical and pharmaceutical sectors. The inclusion of cyclodextrin in biological systems makes hydrophobic medicinal molecules more stable and increases their bioavailability in water. The market is expected to grow faster if dietary supplement consumption were to rise. Cyclodextrin is an example of an excipient that is utilized in the formulation of nutraceutical and medicinal goods.
As a first line of defense against the COVID-19 pandemic, patients have been prescribed a variety of antiviral medications. During the projected period, the market is expected to experience growth due to the increased demand of cyclodextrin caused by the expanding utilization of these medications. An important factor impacting the growth rate of cyclodextrins in the pharmaceutical business is the rising expenditure on healthcare infrastructure. This investment aids in improving the industry's physical facilities. Various government organizations are working to improve healthcare infrastructure by increasing funding, which will have an additional effect on market dynamics. Rising public and commercial sector efforts to bring attention to the issue will also lead to an increase in the use of cyclodextrins in the pharmaceutical sector. Changes in consumer health consciousness and the growing use of cyclodextrins for the treatment of renal diseases bode well for the future of the pharmaceutical industry's cyclodextrins business.
Higher spending on R&D for innovative technologies and more openings in untapped markets will also contribute to the cyclodextrins' meteoric climb in the pharmaceutical sector. Market growth will be hindered, nonetheless, by the exorbitant costs of pharmaceutical research and delivery. The pharmaceutical industry's cyclodextrins market has obstacles in underdeveloped countries due to a lack of healthcare infrastructure and a scarcity of qualified professionals. From 2023 to 2029, the market is expected to be further limited and impeded by stringent regulatory requirements and challenges to conducting diagnostic testing. The supply chain has been disrupted and the healthcare industry's expansion has been slowed down by the outbreak.
As a precaution against the spread of the COVID-19 virus, other countries' governments have also instituted nationwide lockdowns. All throughout the globe, healthcare companies were unable to carry out their supply chain operations due to similar problems. The pharmaceutical industry's sales of cyclodextrins were negatively impacted by the slowness of the supply chain. Nevertheless, numerous agencies are actively attempting to guarantee the ongoing supply of life-saving medications and vaccines now that COVID-19 immunizations are widely available. Eventually, this should lead to the market stabilizing.
The pharmaceutical, food and beverage, medication delivery, chemical, agricultural, and environmental engineering sectors are the most common users of cyclodextrins. As a complex agent that increases the bioavailability of unstable and low water-soluble medicines, cyclodextrins find employment in a wide range of pharmaceutical formulations and oral products. As an example, β-CD is utilized in minoxidil solutions and cetirizine tablets and cisapride suppositories in Europe.
Dietary supplement sales have increased and consumers' shifting views on health have a favorable effect on the industry. Additionally, pharmaceutical and nutraceutical goods utilize cyclodextrin as an excipient. In response to the COVID-19 pandemic, medical practitioners have prescribed numerous antiviral medications to help patients fend against the virus in its early stages. Market expansion would be accelerated throughout the forecast period due to the rising consumption of cyclodextrins caused by the increased utilization of these medications.
Major factors driving the cyclodextrins market expansion include increasing disposable income and the increasing use of cyclodextrins as food additives by the food and beverage sector. The development and expansion of the beverage industry, as well as rising product and usage awareness, are other key elements driving the cyclodextrins market. The nutritional and biological modification benefits of cyclodextrins, as well as their use in medicinal medications, are becoming more well recognized, which bodes well for their market expansion. Increases in westernization, e-commerce growth and expansion (particularly in emerging economies), and platform penetration will all contribute to cyclodextrins market value going up. The cyclodextrins market will experience expansion due to the increased demand for flavors such as mayonnaise. An further factor fueling the expansion of the cyclodextrins market is the increasing use of the ingredient in essential oils.
Report Coverage
Global Cyclodextrin research report categorizes the market for global based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. Global Cyclodextrin report analyses the key growth drivers, opportunities, and challenges influencing the global market. Recent market developments and Cyclodextrin competitive strategies such as expansion, product launch and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key Cyclodextrin market players and analyses their core competencies in each global market sub-segments.
Key Points Covered in the Report
Competitive Environment:
The research provides an accurate study of the major organisations and companies operating in the global Cyclodextrin market, along with a comparative evaluation based on their product portfolios, corporate summaries, geographic reach, business plans, Cyclodextrin market shares in specific segments, and SWOT analyses. A detailed analysis of the firms' recent news and developments, such as product development, inventions, joint ventures, partnerships, mergers and acquisitions, strategic alliances, and other activities, is also included in the study. This makes it possible to assess the level of market competition as a whole.
List of Major Market Participants
CTD Holdings, Inc., Wacker Chemie AG, Cyclolab, Merck KGaA, NIHON SHOKUHIN KAKO CO., LTD., Roquette Frères., Ashland., Shandong Xinda Biological Technology Co., Ltd., Yunan County Yongguang Group, www.ziboqianhui.com, Mengzhou Hongji Biological Co., Ltd., Gangwal Chemicals Pvt. Ltd., Geno, Fengchen Group Co.,Ltd, Cayman Chemical, Zhonglan Industry Co.,Ltd., Shandong Binzhou Zhiyuan Biotechnology Co.,Ltd and Captisol among
Primary Target Market
Market Segment:
This study forecasts global, regional, and country revenue from 2019 to 2031. INFINITIVE DATA EXPERT has segmented the global Cyclodextrin market based on the below-mentioned segments:
Global Cyclodextrin Market, By Type
Alpha
Beta
Gamma
Global Cyclodextrin market, By Application
Pharmaceutical
Food & beverage
Chemicals
Cosmetics & personal care
Others
Global Cyclodextrin market, Regional Analysis
In cyclodextrins, a type of complex cyclic sugar, alpha-1,4 glycosidic bonds link glucose subunits into a macrocyclic ring. Creating cyclodextrin involves breaking down starch into simpler molecules using an enzyme. Cyclodextrin is finding increasing use as a solvent component in medication delivery across the chemical and pharmaceutical sectors. The inclusion of cyclodextrin in biological systems makes hydrophobic medicinal molecules more stable and increases their bioavailability in water. The market is expected to grow faster if dietary supplement consumption were to rise. Cyclodextrin is an example of an excipient that is utilized in the formulation of nutraceutical and medicinal goods.
As a first line of defense against the COVID-19 pandemic, patients have been prescribed a variety of antiviral medications. During the projected period, the market is expected to experience growth due to the increased demand of cyclodextrin caused by the expanding utilization of these medications. An important factor impacting the growth rate of cyclodextrins in the pharmaceutical business is the rising expenditure on healthcare infrastructure. This investment aids in improving the industry's physical facilities. Various government organizations are working to improve healthcare infrastructure by increasing funding, which will have an additional effect on market dynamics. Rising public and commercial sector efforts to bring attention to the issue will also lead to an increase in the use of cyclodextrins in the pharmaceutical sector. Changes in consumer health consciousness and the growing use of cyclodextrins for the treatment of renal diseases bode well for the future of the pharmaceutical industry's cyclodextrins business.
Higher spending on R&D for innovative technologies and more openings in untapped markets will also contribute to the cyclodextrins' meteoric climb in the pharmaceutical sector. Market growth will be hindered, nonetheless, by the exorbitant costs of pharmaceutical research and delivery. The pharmaceutical industry's cyclodextrins market has obstacles in underdeveloped countries due to a lack of healthcare infrastructure and a scarcity of qualified professionals. From 2023 to 2029, the market is expected to be further limited and impeded by stringent regulatory requirements and challenges to conducting diagnostic testing. The supply chain has been disrupted and the healthcare industry's expansion has been slowed down by the outbreak.
As a precaution against the spread of the COVID-19 virus, other countries' governments have also instituted nationwide lockdowns. All throughout the globe, healthcare companies were unable to carry out their supply chain operations due to similar problems. The pharmaceutical industry's sales of cyclodextrins were negatively impacted by the slowness of the supply chain. Nevertheless, numerous agencies are actively attempting to guarantee the ongoing supply of life-saving medications and vaccines now that COVID-19 immunizations are widely available. Eventually, this should lead to the market stabilizing.
The pharmaceutical, food and beverage, medication delivery, chemical, agricultural, and environmental engineering sectors are the most common users of cyclodextrins. As a complex agent that increases the bioavailability of unstable and low water-soluble medicines, cyclodextrins find employment in a wide range of pharmaceutical formulations and oral products. As an example, β-CD is utilized in minoxidil solutions and cetirizine tablets and cisapride suppositories in Europe.
Dietary supplement sales have increased and consumers' shifting views on health have a favorable effect on the industry. Additionally, pharmaceutical and nutraceutical goods utilize cyclodextrin as an excipient. In response to the COVID-19 pandemic, medical practitioners have prescribed numerous antiviral medications to help patients fend against the virus in its early stages. Market expansion would be accelerated throughout the forecast period due to the rising consumption of cyclodextrins caused by the increased utilization of these medications.
Major factors driving the cyclodextrins market expansion include increasing disposable income and the increasing use of cyclodextrins as food additives by the food and beverage sector. The development and expansion of the beverage industry, as well as rising product and usage awareness, are other key elements driving the cyclodextrins market. The nutritional and biological modification benefits of cyclodextrins, as well as their use in medicinal medications, are becoming more well recognized, which bodes well for their market expansion. Increases in westernization, e-commerce growth and expansion (particularly in emerging economies), and platform penetration will all contribute to cyclodextrins market value going up. The cyclodextrins market will experience expansion due to the increased demand for flavors such as mayonnaise. An further factor fueling the expansion of the cyclodextrins market is the increasing use of the ingredient in essential oils.
Report Coverage
Global Cyclodextrin research report categorizes the market for global based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. Global Cyclodextrin report analyses the key growth drivers, opportunities, and challenges influencing the global market. Recent market developments and Cyclodextrin competitive strategies such as expansion, product launch and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key Cyclodextrin market players and analyses their core competencies in each global market sub-segments.
| REPORT ATTRIBUTES | DETAILS |
|---|---|
| Study Period | 2017-2031 |
| Base Year | 2023 |
| Forecast Period | 2023-2031 |
| Historical Period | 2017-2021 |
| Unit | Value (USD Billion) |
| Key Companies Profiled | CTD Holdings, Inc., Wacker Chemie AG, Cyclolab, Merck KGaA, NIHON SHOKUHIN KAKO CO., LTD., Roquette Frères., Ashland., Shandong Xinda Biological Technology Co., Ltd., Yunan County Yongguang Group, www.ziboqianhui.com, Mengzhou Hongji Biological Co., Ltd., Gangwal Chemicals Pvt. Ltd., Geno, Fengchen Group Co.,Ltd, Cayman Chemical, Zhonglan Industry Co.,Ltd., Shandong Binzhou Zhiyuan Biotechnology Co.,Ltd and Captisol among |
| Segments Covered | • By Product |
| Customization Scope | Free report customization (equivalent to up to 3 analyst working days) with purchase. Addition or alteration to country, regional & segment scope |
Key Points Covered in the Report
- Market Revenue of Cyclodextrin Market from 2021 to 2031.
- Market Forecast for Cyclodextrin Market from 2021 to 2031.
- Regional Market Share and Revenue from 2021 to 2031.
- Country Market share within region from 2021 to 2031.
- Key Type and Application Revenue and forecast.
- Company Market Share Analysis, Cyclodextrin competitive scenario, ranking, and detailed company
profiles. - Market driver, restraints, and detailed COVID-19 impact on Cyclodextrin
Market
Competitive Environment:
The research provides an accurate study of the major organisations and companies operating in the global Cyclodextrin market, along with a comparative evaluation based on their product portfolios, corporate summaries, geographic reach, business plans, Cyclodextrin market shares in specific segments, and SWOT analyses. A detailed analysis of the firms' recent news and developments, such as product development, inventions, joint ventures, partnerships, mergers and acquisitions, strategic alliances, and other activities, is also included in the study. This makes it possible to assess the level of market competition as a whole.
List of Major Market Participants
CTD Holdings, Inc., Wacker Chemie AG, Cyclolab, Merck KGaA, NIHON SHOKUHIN KAKO CO., LTD., Roquette Frères., Ashland., Shandong Xinda Biological Technology Co., Ltd., Yunan County Yongguang Group, www.ziboqianhui.com, Mengzhou Hongji Biological Co., Ltd., Gangwal Chemicals Pvt. Ltd., Geno, Fengchen Group Co.,Ltd, Cayman Chemical, Zhonglan Industry Co.,Ltd., Shandong Binzhou Zhiyuan Biotechnology Co.,Ltd and Captisol among
Primary Target Market
- Market Players of Cyclodextrin
- Investors
- End-users
- Government Authorities
- Consulting And Research Firm
- Venture capitalists
- Third-party knowledge providers
- Value-Added Resellers (VARs)
Market Segment:
This study forecasts global, regional, and country revenue from 2019 to 2031. INFINITIVE DATA EXPERT has segmented the global Cyclodextrin market based on the below-mentioned segments:
Global Cyclodextrin Market, By Type
Alpha
Beta
Gamma
Global Cyclodextrin market, By Application
Pharmaceutical
Food & beverage
Chemicals
Cosmetics & personal care
Others
Global Cyclodextrin market, Regional Analysis
- Europe: Germany, Uk, France, Italy, Spain, Russia, Rest of Europe
- The Asia Pacific: China,Japan,India,South Korea,Australia,Rest of Asia Pacific
- South America: Brazil, Argentina, Rest of South America
- Middle East & Africa: UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa
About This Research
You will get in-depth and extensive cyclodextrin market market research and competitor analysis for your business to help you develop more profound insights into the cyclodextrin market Market.
Through INFINITIVE Data Expert is a professional Market Research services, I will identify the cyclodextrin market market size, demand & opportunities, growth rate, and target audience with a comprehensive analysis of your competitors.